AEON Biopharma, Inc

AEONAMEX · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

26.3M

on 2026-06-30, from 529K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-72 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

S-3 of 2024-08-15. Not read yet. S-3 ↗

$3.6M

Leerink Partners, agreement of 2024-08-14. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

55K

Warrants of every class as tagged in the XBRL facts on 2024-12-31. 10-K ↗

Cash

1 quarters

$3.4M on 2026-06-30 ÷ $3.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-07-13	Public offering incl. 24.84M pre-funded	42,688,607	$0.3221	$13.7M	424B4 ↗
2025-01-07	Public offering	40,000,000	$0.50	not read	424B5 ↗

Also on file: a 1-for-72 reverse split, 2025-02-24 8-K ↗